March 2011
DePuy ASR Recipients Urged to Register Their Device
Posted Fri, 03/25/2011 - 14:01
Just a few weeks ago, data from surgeons in the UK showed the DePuy ASR failure rate at 21% at four years, and as high as 49% after only six years. The DePuy recall letter for the ASR hip replacement devices noted revision rates of 12% after five years, but numerous sources and data have clearly shown higher rates of failure than those disclosed by DePuy. The uncertainty of what future data will show about the already failing ASR implant has left many ASR recipients worried.
Filed under:
by admin
DePuy ASR Hip Recall Cases Consolidated in Multidistrict Litigation
Posted Thu, 03/24/2011 - 12:44
In August 2010 DePuy Orthopaedics, Inc., a Johnson & Johnson subsidiary, issued a recall of its ASR XL Hip Replacement System. As a result, thousands of lawsuits against DePuy were filed in courts all over the country. Complex product liability actions, such as the one following the DePuy Recall, require extensive discovery and complicated pre-trial procedures.
Filed under:
by admin
DePuy Parent Company CEO Receives Pay Cut After DePuy Recall
Posted Tue, 03/22/2011 - 14:44
William Weldon, the CEO of Johnson & Johnson (the parent company of DePuy Orthopaedics) has suffered a cut in his total compensation amid company troubles, including the DePuy hip replacement recall.
Filed under:
by admin
Surgery to Revise Recalled DePuy Hip Replacement Proves Complex, Risky and Painful
Posted Wed, 03/16/2011 - 14:15
Studies show that revision surgeries, such as those employed to revise the recalled DePuy hip replacement, are complex, risky and painful. However daunting this surgery may seem, many who were negligently implanted with the defective DePuy hip replacement have no choice other than to submit to the procedure, due to the implant’s high failure rate.
by admin
Australian Class Action Suit on Behalf of 5000 Filed Against DePuy Orthopaedics
Posted Tue, 03/15/2011 - 10:25
On Monday, February 28, 2011, a class action suit was commenced in the Federal Court of Australia against DePuy Orthopaedics. The suit centers around a recalled DePuy ASR hip implant which is manufactured by DePuy Orthopaedics, a subsidiary of Johnson & Johnson. The leading plaintiff in the action is Tammy Sanford, a resident of Hobart, Tasmania.
Filed under:
by admin
DePuy ASR XL Failure Rates Nearly 50%
Posted Mon, 03/14/2011 - 14:24
Important statistics presented at the British Hip Society Annual Conference in early March showed an even higher than anticipated revision rate for the DePuy ASR XL. Data collected from four surgeons in the U.K. showed a 21% revision rate at 4 years and 49% revision rate at 6 years for the recalled DePuy ASR XL hip device. Various reasons for failure include loosening of the acetabular or femoral component and metal reaction leading to death of tissue. In most cases, patients have high cobalt-chromium ion levels and fluid collection around the joint.
Filed under:
by admin
National Joint Registry Finally Underway in the U.S.
Posted Mon, 03/14/2011 - 11:57
The American Association of Orthopaedic Surgeons estimates that around 800,000 joint replacements take place in the United States each year, and the time has finally come for the U.S. to establish a joint registry, The American Joint Replacement Registry. The United Kingdom, Australia, and Sweden are just a few of the countries that have national joint registries, which monitor the performances of devices.
Filed under:
by admin
DePuy Orthopaedics President Resigns Following Recall of DePuy Hip Replacement
Posted Sat, 03/12/2011 - 14:09
David Floyd, president of DePuy Orthopaedics, manufacturing knee and hip replacements sold worldwide, has resigned his post amidst growing company struggles in the wake of the DePuy hip replacement recall.
A spokeswoman confirmed on Monday that Mr. Floyd had tendered his resignation in the last week of February, citing the pursuit of interests outside of DePuy Orthopaedics. Mr. Floyd will continue as president at DePuy Orthopaedics, a position he assumed in 2007, through a transition period which will end in late March.
by admin
The FDA Could Have Warned Patients Sooner About the Defective ASR
Posted Sat, 03/12/2011 - 13:28
When DePuy Orthopaedics recalled the ASR XL Acetabular System and ASR Hip Resurfacing System last August, it did so voluntarily, without any warnings from the Food and Drug Administration. By this time, there was ample amount of data and reports, accumulated through a few years, which showed the unusually high revision rate associated with the ASR hip implant.
Filed under:
by admin
"Is My DePuy Hip Implant Malfunctioning?"
Posted Sat, 03/12/2011 - 13:02
Many recipients of the DePuy ASR hip implant system have been put in a difficult situation with the recent recall of that implant. The question foremost in the minds of most of those patients upon receiving the news is “What am I supposed to do now?” If you are one of those people who was implanted with a DePuy ASR it is important that you take immediate action to determine whether your hip implant is malfunctioning.
Filed under:
by admin
